Description: Cogstate is a leading cognitive science company focused on optimizing the measurement of cognition to guide decision-making in clinical trials, academic research and healthcare. Cogstate commercializes rapid, reliable and highly sensitive computerized cognitive tests and provides expert support for traditional neurological assessments. Our products and services have been used in hundreds of clinical trials, guiding decision-making for cognitive safety and efficacy across many indications and all phases of development. Cogstate’s unique combination of science, service and technology allows us to deliver solutions to the most pressing challenges for reliable clinical assessments of cognition.
Home Page: www.cogstate.com
161 Collins Street
Melbourne,
VIC
3000
Australia
Phone:
61 3 9664 1300
Officers
| Name | Title |
|---|---|
| Mr. Bradley John O'Connor B.Bus, C.A., CA | CEO, MD & Exec. Director |
| Prof. Paul Maruff BBSc (Hons), Ph.D. | Founder & Chief Innovation Officer |
| Mr. Darren Watson | Chief Financial Officer |
| Mr. Benjamin Bloomfield | Chief Technology Officer |
| Mr. Kenneth Billard | Chief Commercial Officer |
| Dr. Chris Edgar Ph.D. | Chief Science Officer |
| Ms. Rachel Colite | VP of Strategic Initiatives, Communication & People |
| Mr. David James Franks B.Ec, BEc, C.A., CA, F Fin, J.P., JP. | Company Sec. |
| Dr. Amy E. Veroff Ph.D. | Principal Consultant |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
| Forward PE: | 31.0559 |
|---|---|
| Trailing PE: | 33 |
| Price-to-Book MRQ: | 6.269 |
| Price-to-Sales TTM: | 4.7563 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 380 |